Chad Pettit, MBA

 

Executive Director, Marketing, Biosimilars Business Unit, Amgen

 

As Executive Director, Marketing for Amgen’s Biosimilars Business Unit, Chad Pettit leads the Global Biosimilars Commercial Team in developing global launch strategy for Amgen’s portfolio biosimilar medicines. With his global experience, Chad is recognized as an expert on biosimilar commercialization, market access for biosimilars, and the policy measures required to facilitate cost savings for patients and the healthcare system over the long run.

Chad received his MBA from the University of California Los Angeles, Anderson School of Management, and holds a BS in Chemical Engineering from the University of California Davis. In his spare time, he provides leadership and service within the community, enjoys the outdoors, and spends time with his wife Amy and four children.